Improvement in islet yield from obese donors for human islet transplants

Transplantation

Volumn 78, Issue 6, 2004, Pages 880-885

  Matsumoto, Ippei ^a   Sawada, Toshiya ^a   Nakano, Masahiko ^a   Sakai, Tetsuya ^a   Liu, Baolin ^a   Ansite, Jeffrey D ^a   Zhang, Hui Jian ^a   Kandaswamy, Raja ^a   Sutherland, David E R ^a   Hering, Bernhard J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Body mass index; Donor factors; Human islet isolation; Human islet transplantation; Obese donors

Indexed keywords

ARTICLE; BIOASSAY; BODY MASS; CADAVER DONOR; CELL ISOLATION; CONTROLLED STUDY; DENSITY GRADIENT; HUMAN; HUMAN CELL; IN VITRO STUDY; NUDE MOUSE; OBESITY; ORGAN DONOR; ORGAN WEIGHT; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; PURIFICATION;

ADULT; ANIMALS; BODY MASS INDEX; CAUSE OF DEATH; CELL SEPARATION; FEMALE; GLUCOSE; GRAFT SURVIVAL; HUMANS; INSULIN; ISLETS OF LANGERHANS; MALE; MICE; MICE, NUDE; OBESITY; RETROSPECTIVE STUDIES; TIME FACTORS; TISSUE AND ORGAN HARVESTING; TISSUE DONORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 4644328938     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000134396.03440.1E     Document Type: Article

References (28)

1. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
2. Ryan EA, Lakey JRT, Rajotte RV, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001;50:710.
3. Lakey JRT, Warnock GL, Rajotte RV, et al. Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation 1996; 61: 1047.
4. Zeng Y, Torre MA, Karrison T, et al. The correlation between donor characteristics and the success of human islet isolation. Transplantation 1994; 57: 954.
5. Benhamou PY, Watt PC, Mullen Y, et al. Human islet isolation in 104 consecutive cases. Transplantation 1994; 57: 1804.
6. Toso C, Oberholzer J, Ris F, et al. Factors affecting human islet of Langerhans isolation yields. Transplant Proc 2002; 34: 826.
7. Lakey JRT, Rajotte RV, Warnock GL, et al. Human pancreas preservation prior to islet isolation: Cold ischemic tolerance. Transplantation 1995; 59: 689.
8. Bartlett ST, Kuo PC, Johnson LB, et al. Pancreas transplantation at the University of Maryland. Clin Transpl 1996; 271.
9. Knight RJ, Bodian C, Rodrignez-Laiz G, et al. Risk factors for intraabdominal infection after pancreas transplantation. Am J Surg 2000; 179: 99.
10. Stratta RJ, Taylor RJ, Sindhi R, et al. Early graft loss after pancreas transplantation: an analysis of risk factors. Presented at the 7th World Congress of the International Pancreas and Islet Transplant Association, Sydney, Australia, August 1999.
11. Matsumoto S, Kuroda Y. Perfluorocarbon for organ preservation before transplantation. Transplantation 2002; 74: 1804.
12. Ricordi C, Lacy PE, Finke EH, et al. Automated method for isolation of human pancreatic islets. Diabetes 1988; 37: 413.
13. Lakey JR, Warnock GL, Shapiro AM, et al. Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant 1999; 8: 285.
14. Van der Burg MPM, Ranuncoli A, Molano R, et al. OptiPrep for human islet purification. Cell Transplant 1999; 8: 184.
15. Ricordi C, Gray DWR, Hering BJ, et al. Islet isolation assessment in man and large animals. Acta Diabetol Lat 1990; 27: 185.
16. Brandhorst H, Brandhorst D, Hering BJ, et al. Body mass index of pancreatic donors: a decisive factor for human islet isolation. Exp Clin Endocrinol Diabetes 1995; 103: 23.
17. Kahn SE, Prigeon RL, Schwartz RS, et al. Obesity, body fat distribution, insulin sensitivity and islet beta-cell function as explanations for metabolic diversity. J Nutr 2001; 131: 354S.
18. Mahler R, Franke FE, Hering BJ, et al. Evidence for a significant correlation of donor pancreas morphology and the yield of isolated purified human islets. J Mol Med 1999; 77: 87.
19. Zuniga-Guajardo S, Jimenez J, Angel A, et al. Effects of massive obesity on insulin sensitivity and insulin clearance and metabolic response to insulin as assessed by the euglycemic clamp technique. Metabolism 1986; 35: 278.
20. Perley M, Kipnis DM. Plasma insulin response to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects. Diabetes 1966; 15: 867.
21. Larsson H, Ahren B. Islet dysfunction in obese women with impaired glucose tolerance. Metabolism 1996; 45: 502.
22. Lucocq JM, Findlay JA. Islet organ, blood glucose and glucose tolerance of lean and obese Mongolian gerbils: a quantitative study. Cell Tissue Res 1981; 220: 623.
23. Edvell A, Lindstrom P. Initiation of increased pancreatic islet growth in young normoglycemic mice. Endocrinology 1999; 140: 778.
24. Janssen SW, Hermus AR, Lange WP, et al. Progressive histopathological changes in pancreatic islets of Zucker Diabetic Fatty rats. Exp Clin Endocrinol Diabetes 2001; 109: 273.
25. Kanazawa M, Tanaka A, Nomoto S, et al. Alterations of insulin and glucagon secretion from the perfused pancreas before, at the onset and after the development of diabetes in male Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Diabetes Res Clin Pract 1997; 38: 161.
26. Finegood DT, McArthur MD, Kojwang D, et al. Beta-cell mass dynamics in Zucker diabetic fatty rats: rosiglitazone prevents the rise in net cell death. Diabetes 2001; 50: 1021.
27. Butler AE, Janson J, Bonner-Weir S, et al. β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52: 102.
28. Hayek A. Insulin and glucagon release from cultured neonatal pancreatic islets of lean and preobese Zucker rats. Diabetes 1982; 31: 944.